Diamines & Chemicals Ltd
Incorporated in 1976, Diamines and Chemicals Ltd is in the business of manufacturing and marketing of organic chemicals compounds[1]
- Market Cap ₹ 530 Cr.
- Current Price ₹ 542
- High / Low ₹ 693 / 446
- Stock P/E 63.5
- Book Value ₹ 170
- Dividend Yield 0.46 %
- ROCE 16.9 %
- ROE 12.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 21.7%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
57.40 | 43.94 | 39.09 | 35.58 | 34.78 | 38.51 | 47.32 | 69.30 | 62.82 | 65.97 | 110.34 | 103.98 | 88.39 | |
49.28 | 38.04 | 34.12 | 31.12 | 25.44 | 26.92 | 28.38 | 34.07 | 37.66 | 43.89 | 54.48 | 79.79 | 76.42 | |
Operating Profit | 8.12 | 5.90 | 4.97 | 4.46 | 9.34 | 11.59 | 18.94 | 35.23 | 25.16 | 22.08 | 55.86 | 24.19 | 11.97 |
OPM % | 14.15% | 13.43% | 12.71% | 12.54% | 26.85% | 30.10% | 40.03% | 50.84% | 40.05% | 33.47% | 50.63% | 23.26% | 13.54% |
0.23 | 0.30 | 0.18 | 0.36 | 0.07 | -1.08 | 0.96 | 2.09 | 2.55 | 1.79 | 2.65 | 2.73 | 3.13 | |
Interest | 3.81 | 2.98 | 3.41 | 2.75 | 1.73 | 0.32 | 0.07 | 0.08 | 0.08 | 0.09 | 0.14 | 0.19 | 0.16 |
Depreciation | 2.39 | 2.43 | 2.03 | 1.99 | 1.95 | 1.95 | 2.01 | 2.06 | 1.79 | 1.67 | 1.71 | 2.66 | 3.14 |
Profit before tax | 2.15 | 0.79 | -0.29 | 0.08 | 5.73 | 8.24 | 17.82 | 35.18 | 25.84 | 22.11 | 56.66 | 24.07 | 11.80 |
Tax % | 20.93% | 5.06% | 431.03% | -212.50% | 16.40% | 13.96% | 26.32% | 31.81% | 18.61% | 24.33% | 25.50% | 26.17% | |
1.70 | 0.75 | -1.55 | 0.25 | 4.80 | 7.09 | 13.13 | 23.99 | 21.03 | 16.72 | 42.22 | 17.77 | 8.35 | |
EPS in Rs | 1.74 | 0.77 | -1.58 | 0.26 | 4.91 | 7.25 | 13.42 | 24.52 | 21.50 | 17.09 | 43.16 | 18.16 | 8.53 |
Dividend Payout % | 28.76% | 0.00% | 0.00% | 0.00% | 30.56% | 34.49% | 37.24% | 32.61% | 23.25% | 17.55% | 6.95% | 13.76% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 17% |
3 Years: | 18% |
TTM: | -21% |
Compounded Profit Growth | |
---|---|
10 Years: | 37% |
5 Years: | 6% |
3 Years: | -6% |
TTM: | -72% |
Stock Price CAGR | |
---|---|
10 Years: | 31% |
5 Years: | 30% |
3 Years: | 27% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | 22% |
5 Years: | 25% |
3 Years: | 22% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
Reserves | 24.68 | 25.33 | 23.58 | 23.84 | 27.79 | 32.83 | 39.03 | 55.40 | 75.24 | 90.46 | 125.10 | 140.99 | 156.68 |
19.53 | 19.75 | 20.10 | 15.56 | 6.96 | 0.00 | 1.99 | 0.00 | 0.30 | 0.00 | 0.00 | 0.00 | 4.43 | |
11.91 | 10.35 | 10.04 | 8.64 | 9.47 | 10.04 | 11.14 | 11.16 | 9.49 | 10.35 | 16.56 | 14.41 | 17.38 | |
Total Liabilities | 65.90 | 65.21 | 63.50 | 57.82 | 54.00 | 52.65 | 61.94 | 76.34 | 94.81 | 110.59 | 151.44 | 165.18 | 188.27 |
33.23 | 31.51 | 29.30 | 27.33 | 25.45 | 24.14 | 24.45 | 20.41 | 22.47 | 37.55 | 26.89 | 50.38 | 49.60 | |
CWIP | 0.42 | 0.00 | 0.00 | 0.00 | 0.21 | 0.52 | 0.79 | 1.16 | 0.15 | 1.88 | 21.39 | 0.83 | 1.48 |
Investments | 0.15 | 0.15 | 0.15 | 0.13 | 0.93 | 0.66 | 0.25 | 2.07 | 5.99 | 12.87 | 26.76 | 29.63 | 34.16 |
32.10 | 33.55 | 34.05 | 30.36 | 27.41 | 27.33 | 36.45 | 52.70 | 66.20 | 58.29 | 76.40 | 84.34 | 103.03 | |
Total Assets | 65.90 | 65.21 | 63.50 | 57.82 | 54.00 | 52.65 | 61.94 | 76.34 | 94.81 | 110.59 | 151.44 | 165.18 | 188.27 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15.32 | 5.60 | 4.66 | 7.27 | 8.88 | 9.92 | 12.50 | 25.95 | 15.37 | 27.31 | 16.31 | 19.73 | |
-4.61 | -2.29 | -1.65 | -0.06 | 0.65 | -2.91 | -8.51 | -13.04 | -14.98 | -21.64 | -8.57 | -16.65 | |
-10.78 | -3.33 | -3.06 | -7.29 | -9.55 | -6.54 | -4.57 | -9.17 | -3.69 | -5.28 | -6.01 | -3.13 | |
Net Cash Flow | -0.07 | -0.02 | -0.06 | -0.08 | -0.02 | 0.47 | -0.59 | 3.75 | -3.29 | 0.39 | 1.73 | -0.05 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 65.75 | 67.04 | 72.74 | 75.71 | 86.58 | 74.88 | 59.01 | 65.78 | 54.79 | 55.44 | 75.72 | 58.62 |
Inventory Days | 122.26 | 184.13 | 192.70 | 155.05 | 195.07 | 185.25 | 301.04 | 197.45 | 283.59 | 43.30 | 233.57 | 135.03 |
Days Payable | 58.39 | 66.67 | 54.67 | 34.46 | 48.26 | 100.47 | 131.14 | 80.67 | 64.90 | 44.80 | 104.92 | 40.17 |
Cash Conversion Cycle | 129.62 | 184.50 | 210.77 | 196.31 | 233.39 | 159.66 | 228.91 | 182.56 | 273.47 | 53.93 | 204.37 | 153.48 |
Working Capital Days | 85.40 | 110.81 | 129.79 | 115.20 | 199.71 | 88.43 | 86.39 | 75.63 | 104.53 | 39.61 | 97.09 | 108.08 |
ROCE % | 10.48% | 6.93% | 5.76% | 5.14% | 15.92% | 23.16% | 38.28% | 60.68% | 34.45% | 23.96% | 48.40% | 16.92% |
Documents
Announcements
-
Compliance Of Reg 32
24 Oct - Disclosure of fund raising and utilization for Q3 2024.
-
Unaudited Financial Result
24 Oct - Approval of financial results and investments in subsidiaries.
-
Board Meeting Outcome for Outcome Of Board Meeting
24 Oct - Board meeting outcome and financial results approved.
-
Board Meeting Outcome for Outcome Of Board Meeting
24 Oct - Approval of financial results and investments in subsidiaries.
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
23 Oct - Intimation of duplicate share certificate issuance.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
DCL is an ISO 9001:2015, ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018, and DSIR-certified sole manufacturer of ethylene amines in India. It also manufactures Piperazine Anhydrous and Piperazine Solutions.